Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Research

Margin status impact on recurrence of phyllodes tumors in high-risk groups: a retrospective observational study

Authors: Aliyeh Ranjbar, Vahid Zangouri, Mansoureh Shokripour

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Phyllodes tumor (PT) is an fibroepithelial tumor with potential for local recurrence. The optimal margin for surgical resection of PT is still debated, particularly in cases of positive margins. This study aimed to identify the risk factors for phyllodes tumor recurrence and the effect of a free margin on tumor recurrence by considering these risk factors.

Materials and methods

This is a retrospective observational study of patients diagnosed with PT who had undergone surgical management. The data were collected from medical records from 2001 to 2020 in the breast clinic of Shahid Motahhari Clinic of Shiraz. Patients were followed up for at least 3 years after the operation to be checked for local recurrence or distant metastasis at regular intervals.

Results

This retrospective study included 319 patients with PT who underwent surgical management. Of these patients, 83.9% (n = 267), 7.6% (n = 24), and 8.5% (n = 27) were classified as benign, borderline, and malignant, respectively. 8.8% of all patients and 7.6% of non-malignant cases experienced local recurrence, and risk factors for recurrence included oral contraceptive use, smoking, size > 4 cm, stromal overgrowth, and stromal cell atypia. A negative surgical margin decreased the prevalence of recurrence in tumors > 4 cm and with stromal overgrowth significantly.

Conclusion

The study found that a negative margin in all patients did not reduce the recurrence rate in benign and borderline phyllodes tumors, suggesting close follow up as a reasonable alternative. However, a negative margin may be effective in reducing recurrence in certain high-risk groups.
Literature
1.
Reinfuss M, Mituś J, Duda K, Stelmach A, Ryś J, Smolak K. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer: Interdisciplinary International Journal of the American Cancer Society. 1996;77(5):910–6.CrossRef
2.
Guerrero MA, Ballard BR, Grau AM. Malignant phyllodes tumor of the breast: review of the literature and case report of stromal overgrowth. Surg Oncol. 2003;12(1):27–37.CrossRefPubMed
3.
Guillot E, Couturaud B, Reyal F, Curnier A, Ravinet J, Laé M, et al. Management of phyllodes breast tumors. Breast J. 2011;17(2):129–37.CrossRefPubMed
4.
5.
6.
7.
Yilmaz E, Sal S, Lebe B. Differentiation of phyllodes tumors versus fibroadenomas: mammographic and sonographic features. Acta Radiol. 2002;43(1):34–9.PubMed
8.
Michaud P, Chave B, Lemaire B, Maitre F, Tescher M. Les tumeurs phyllodes du sein. Rev Fr Gynecol Obstet. 1989;84(12):944–9.PubMed
9.
Liberman L, Bonaccio E, Hamele-Bena D, Abramson AF, Cohen MA, Dershaw DD. Benign and malignant phyllodes tumors: mammographic and sonographic findings. Radiology. 1996;198(1):121–4.CrossRefPubMed
10.
Vos D, Mastboom W, De Vos R. Phyllodes tumor in the breast. Ned Tijdschr Geneeskd. 1998;142(13):716–21.PubMed
11.
Iau P, Lim T, Png D, Tan W. Phyllodes tumour: an update of 40 cases. Ann Acad Med Singapore. 1998;27(2):200–3.PubMed
12.
Shet T, Rege J. Cystic degeneration in phyllodes tumor. A source of error in cytologic interpretation. Acta Cytol. 2000;44(2):163–8.CrossRefPubMed
13.
14.
15.
Sallusti E, Simonelli I, Marzullo A, Peis A, Modesti M. [The breast phyllodes tumor: surgical therapy following histological transformation. Case Report] G Chir. 2004;25(3):95–7. Epub 2004/07/01. PubMed PMID: 15224663.PubMed
16.
Gabriele R, Borghese M, Corigliano N, Barbaro M, Conte M. Phyllodes tumor of the breast. Personal contribution of 21 cases. Il Giornale Di Chirurgia. 2000;21(11–12):453–6.PubMed
17.
18.
Mangi AA, Smith BL, Gadd MA, Tanabe KK, Ott MJ, Souba WW. Surgical management of phyllodes tumors. Arch Surg. 1999;134(5):487–93.CrossRefPubMed
19.
20.
Moo T-A, Alabdulkareem H, Tam A, Fontanet C, Lu Y, Landers A, et al. Association between recurrence and re-excision for close and positive margins versus observation in patients with benign phyllodes tumors. Ann Surg Oncol. 2017;24(10):3088–92.CrossRefPubMed
21.
Ouyang Q, Li S, Tan C, Zeng Y, Zhu L, Song E, et al. Benign phyllodes tumor of the breast diagnosed after ultrasound-guided vacuum-assisted biopsy: surgical excision or wait-and-watch? Ann Surg Oncol. 2016;23:1129–34.CrossRefPubMed
22.
Rosenberger LH, Thomas SM, Nimbkar SN, Hieken TJ, Ludwig KK, Jacobs LK, et al. Contemporary multi-institutional cohort of 550 cases of phyllodes tumors (2007–2017) demonstrates a need for more individualized margin guidelines. J Clin Oncol. 2021;39(3):178.CrossRefPubMed
23.
Genco IS, Purohit V, Hackman K, Ferreira L, Tugertimur B, Hajiyeva S. Benign and borderline phyllodes tumors of the breast: clinicopathologic analysis of 205 cases with emphasis on the surgical margin status and local recurrence rate. Annals of Diagnostic Pathology. 2021;51:151708.CrossRefPubMed
24.
Gradishar WJ, Moran MS, Abraham J, Aft R, Agnese D, Allison KH, et al. Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20(6):691–722.CrossRefPubMed
25.
Nair NS, Chitkara G, Hawaldar RW, Parmar V, Joshi S, Thakkar P, et al. En bloc excision of phyllodes tumor of the breast: radical approach heralds better outcome. Clin Breast Cancer. 2021;21(3):e228–e34.CrossRefPubMed
26.
Toussaint A, Piaget-Rossel R, Stormacq C, Mathevet P, Lepigeon K, Taffe P. Width of margins in phyllodes tumors of the breast: the controversy drags on?—a systematic review and meta-analysis. Breast Cancer Res Treat. 2021;185:21–37.CrossRefPubMed
27.
Moldoveanu D, Iny E, Theriault C, Florea A, Wong SM, Basik M, et al. Margin status and local recurrence in phyllodes tumours of the breast: a Canadian series. Ann Surg Oncol. 2023;30(3):1700–9.CrossRefPubMed
28.
Chao X, Jin X, Tan C, Sun P, Cui J, Hu H et al. Re-excision or wait and watch—a prediction model in breast phyllodes tumors after surgery. Annals of Translational Medicine. 2020;8(6).
29.
Kim YY, Kim H, Kim WY, Chung JH, Lee JB, Woo SU. Under-and Normal-Weight Patients Are More Susceptible to Recurrence of Phyllodes Tumor. The Breast Journal. 2022;2022.
30.
Borhani-Khomani K, Talman M-LM, Kroman N, Tvedskov TF. Risk of local recurrence of benign and borderline phyllodes tumors: a Danish population-based retrospective study. Ann Surg Oncol. 2016;23:1543–8.CrossRefPubMed
31.
Lu Y, Chen Y, Zhu L, Cartwright P, Song E, Jacobs L, et al. Local recurrence of benign, borderline, and malignant phyllodes tumors of the breast: a systematic review and meta-analysis. Ann Surg Oncol. 2019;26:1263–75.CrossRefPubMed
32.
Sharma A, Hyde K, Ferguson D. Benign and Borderline Phyllodes: management and Follow-Up: Phyllodes Management. Archives of Breast Cancer. 2022:398–400.
33.
Tan EY, Hoon TP, Yong WS, Wong HB, Hui HG, Yeo AW, et al. Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg. 2006;76(6):476–80.CrossRefPubMed
34.
Wei J, Tan Y-T, Cai Y-C, Yuan Z-Y, Yang D, Wang S-S, et al. Predictive factors for the local recurrence and distant metastasis of phyllodes tumors of the breast: a retrospective analysis of 192 cases at a single center. Chin J cancer. 2014;33(10):492.PubMedPubMedCentral
35.
Barth RJ. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat. 1999;57:291–5.CrossRefPubMed
36.
37.
38.
Ravindhran B, Rajan S. Predictive factors of early recurrence in patients with phyllodes tumor of the breast. Eur J Breast Health. 2021;17(1):10.PubMed
Metadata
Title
Margin status impact on recurrence of phyllodes tumors in high-risk groups: a retrospective observational study
Authors
Aliyeh Ranjbar
Vahid Zangouri
Mansoureh Shokripour
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11805-2

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue

Research

Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia

Research

Impact of the COVID-19 pandemic in childhood and adolescent cancer care in northern Tanzania: a cross-sectional study

Research

The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis

Research

Impact of the Sars-Cov-2 outbreak on the initial clinical presentation of new solid cancer diagnoses: a systematic review and meta-analysis

Research

Prognostic impact of chronic lymphocytic leukemia comorbidity index in a young population: a real-world evidence study of a national gulf region cohort

Research

Red blood cell distribution width is associated with sarcopenia risk in early-stage non-small cell lung cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits